Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protease activated receptor 2 (PAR2) is a widely expressed class-A GPCR that acts as a sensor for endogenous/exogenous serine proteases. It plays critical roles across inflammation/immunity/homeostasis/cancer/metabolism by integrating signals from its unique irreversible mode of activation. Its complex regulation involves both classical G protein-dependent pathways and β-arrestin scaffolding functions.
Agonist binding, proteolytic cleavage exposing tethered ligand, G protein activation, β-arrestin recruitment
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protease-activated receptor 2 (PAR2).